Roderick De Greef Biolife Solutions Inc (BLFS) insider trading activity

BLFS Quotes by TradingView

Roderick De Greef is President and CEO of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 461,854 shares of BLFS, which is worth approximately $10 Million. The most recent transaction as insider was on Mar 12, 2024, when has been sold 7,249 shares (Common Stock) at a price of $16.6 per share, resulting in proceeds of $120,333. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 462K
0% 3M change
4.36% 12M change
Total Value Held $10 Million

RODERICK DE GREEF Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 12 2024
SELL
Open market or private sale
$120,333 $16.6 p/Share
7,249 Reduced 1.55%
461,854 Common Stock
Mar 08 2024
BUY
Grant, award, or other acquisition
-
29,206 Added 5.86%
469,103 Common Stock
Jan 19 2024
SELL
Open market or private sale
$44,279 $16.76 p/Share
2,642 Reduced 0.6%
439,897 Common Stock
Oct 19 2023
BUY
Grant, award, or other acquisition
-
394,856 Added 47.15%
442,539 Common Stock
Oct 01 2023
BUY
Grant, award, or other acquisition
-
362 Added 0.79%
45,262 Common Stock
Mar 31 2023
BUY
Exercise of conversion of derivative security
-
4,740 Added 9.55%
44,900 Common Stock
Jan 19 2023
BUY
Open market or private sale
$88,145 $23.19 p/Share
3,801 Added 8.65%
40,160 Common Stock
Jan 04 2023
BUY
Grant, award, or other acquisition
-
9,647 Added 18.0%
43,961 Common Stock
Nov 30 2022
SELL
Open market or private sale
$698,103 $20.59 p/Share
33,905 Reduced 49.7%
34,314 Common Stock
Nov 29 2022
SELL
Open market or private sale
$30,300 $20.2 p/Share
1,500 Reduced 2.15%
68,219 Common Stock
Nov 28 2022
SELL
Open market or private sale
$211,000 $21.1 p/Share
10,000 Reduced 12.54%
69,719 Common Stock
Nov 23 2022
SELL
Open market or private sale
$97,695 $21.71 p/Share
4,500 Reduced 5.34%
79,719 Common Stock
Nov 21 2022
SELL
Open market or private sale
$205,485 $21.63 p/Share
9,500 Reduced 10.14%
84,219 Common Stock
Nov 18 2022
SELL
Open market or private sale
$33,195 $22.13 p/Share
1,500 Reduced 1.58%
93,719 Common Stock
Nov 16 2022
SELL
Open market or private sale
$34,815 $23.21 p/Share
1,500 Reduced 1.55%
95,219 Common Stock
Nov 14 2022
SELL
Open market or private sale
$481,000 $24.05 p/Share
20,000 Reduced 17.14%
96,719 Common Stock
Oct 07 2022
SELL
Open market or private sale
$194,045 $22.69 p/Share
8,552 Reduced 6.83%
116,719 Common Stock
Oct 03 2022
SELL
Open market or private sale
$27,064 $21.95 p/Share
1,233 Reduced 0.97%
125,271 Common Stock
Aug 14 2022
BUY
Grant, award, or other acquisition
-
535 Added 0.42%
126,504 Common Stock
Jul 29 2022
BUY
Grant, award, or other acquisition
-
683 Added 0.54%
125,969 Common Stock
Jul 17 2022
BUY
Grant, award, or other acquisition
-
828 Added 0.66%
125,286 Common Stock
Jul 12 2022
SELL
Open market or private sale
$144,605 $15.79 p/Share
9,158 Reduced 6.85%
124,458 Common Stock
Jul 03 2022
BUY
Grant, award, or other acquisition
-
900 Added 0.67%
133,616 Common Stock
Jun 19 2022
BUY
Grant, award, or other acquisition
-
955 Added 0.71%
132,716 Common Stock
Jun 05 2022
BUY
Grant, award, or other acquisition
-
957 Added 0.72%
131,761 Common Stock
RDG

Roderick De Greef

President and CEO
Bothell, WA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BLFS